By: ALARIC DEARMENT From: medcitynews.com Perhaps it was inevitable that with Food and Drug Administration Commissioner Scott Gottlieb speaking before an auditorium full of biotechnology executives, a particularly contentious topic would come up: the new right-to-try law. Gottlieb was at the BIO annual meeting in Boston Thursday for a fireside chat with the organization’s president, Jim Greenwood. During the question-and-answer session, …
-
-
Breast Cancer Survivors Making a Difference in Breast Cancer Awareness Month
-
Pain for a Breast Cancer Survivor
-
A World Turned Upside Down After a Breast Cancer Diagnosis
-
This Breast Cancer Survivor Won’t Settle for Being Mediocre
-
Please Don’t Tell a Breast Cancer Survivor What To Do
